Concepedia

Max V. Sigal

MV

Statistics

Publications

15

Citations

796

H-Index

12

Active since

1954

Affiliations

Eli Lilly (United States)(Current)

Max V. Sigal is an author at Eli Lilly (United States) specializing in pharmacology, medicine, and drug discovery.

Top concepts

Publications per year

1954–1963

15

Publications

15

Erythromycin. I. Properties and Degradation Studies<sup>1</sup>

Edwin H. Flynn, Max V. Sigal, Paul F. Wiley et al. · Journal of the American Chemical Society · 1954 · 204 citations

, , +20

Erythromycin. X.<sup>1</sup> Structure of Erythromycin

Paul F. Wiley, Koert Gerzon, Edwin H. Flynn et al. · Journal of the American Chemical Society · 1957 · 151 citations

, , +16

Some insulin-like effects of nicotinic acid observed with isolated rat epididymal adipose tissue

Henry M. Lee, Robert M. Ellis, Max V. Sigal · Biochimica et Biophysica Acta · 1961 · 135 citations

, , +12

Erythromycin. VIII. Structure of Dihydroerythronolide<sup>1</sup>

Koert Gerzon, Edwin H. Flynn, Max V. Sigal et al. · Journal of the American Chemical Society · 1956 · 53 citations

, , +15

Erythromycin. XI.<sup>1</sup> Structure of Erythromycin B<sup>2</sup>

Paul F. Wiley, Max V. Sigal, Ollidene Weaver et al. · Journal of the American Chemical Society · 1957 · 42 citations

, , +17

1–5 of 15